🤖 This page was written by AI and reviewed by a human. 2026-07-15. Version 0.17
David Sackler
Status
Born in 1980. Living in New York, New York.
Criminal status: No personal criminal convictions. Named defendant in Massachusetts AG complaint (June 2018) and amended complaint (January 2019); named in California AG amended complaint (October 2019); named as one of five "Named Sacklers" in DOJ civil settlement (October 2020, family paid USD 225M); named in USD 7.4B national multistate settlement (January 2025). That settlement became legally effective April 1, 2026, and Purdue Pharma dissolved on May 1, 2026, permanently barring the Sackler family from selling opioids in the United States.
Summary
David Sackler is the son of Richard Sackler, the former president and chairman of Purdue Pharma, maker of OxyContin. He serves as president of Summer Road LLC, a family office managing a portion of the Sackler family's wealth derived from OxyContin sales.
Sackler served on Purdue Pharma's board of directors from 2012 to 2018, a period during which federal prosecutors found the company intensified its opioid marketing to the highest-volume prescribers in the country. He was named by the Department of Justice in October 2020 as one of five "Named Sacklers" whose conduct gave rise to the civil settlement. In January 2025, he was named in the largest individual opioid settlement in US history — a USD 7.4 billion agreement with all 55 US attorneys general that ended the Sackler family's control of Purdue Pharma and barred them from selling opioids in the United States.
The settlement took legal effect on April 1, 2026, and Purdue Pharma dissolved on May 1, 2026, with its pharmaceutical operations transferring to a new public-benefit successor, Knoa Pharma LLC.
Business Relationships
Sackler leads Summer Road LLC, a private investment firm managing assets for the Richard Sackler family, including the Cap 1 controlling stake in Peak Resorts that was sold to Vail Resorts in 2019.
Ownership
David Sackler serves as president of Summer Road LLC, a single-family office that manages investments for the Richard Sackler branch of the Sackler family. Through Summer Road, Sackler served as investment manager for Cap 1 LLC, a Delaware holding company that held a 54% controlling stake in Peak Resorts, the ski resort operator. Cap 1 was sold to Vail Resorts in July 2019. Sackler also held a direct 0.7% personal stake in Peak Resorts.
Sackler served on Purdue Pharma's board of directors from 2012 to 2018. He resigned from the board concurrent with other Sackler family members in 2018 as litigation against the company accelerated.
Family & Heirs
David Sackler is the son of Richard Sackler and Beth Sackler, and the grandson of Raymond Sackler, one of the brothers who founded Purdue Pharma in 1952. He has three children, as he mentioned in a 2019 Vanity Fair interview.
Evidence
2012-01-01 - 😈 - Joined Purdue Pharma board of directors in 2012, serving through 2018 during company's aggressive OxyContin marketing
2013-01-01 - 😈 - As Named Sackler, approved "Evolve to Excellence" opioid marketing program targeting doctors writing 25x more OxyContin prescriptions than peers
2013-07-01 - 😈 - Directed Purdue email initiatives targeting Massachusetts prescribers and payments to doctors to promote deceptive OxyContin savings card scheme
2018-03-08 - 😈 - Purchased USD 22.5 million Bel Air mansion in cash at peak of opioid crisis using OxyContin-derived family wealth
2019-01-31 - 😈 - Named as personal defendant in Massachusetts AG amended complaint alleging he directed deceptive OxyContin marketing scheme
2019-04-18 - 😈 - Managed family's 54% Cap 1 stake in Peak Resorts through Summer Road family office and personally held 0.7% stake
2019-06-20 - 😈 - In Vanity Fair interview, denied Purdue Pharma and the Sackler family caused the opioid crisis despite documented board role
2019-07-22 - 😈 - Sackler family benefited from USD 87 million sale of Peak Resorts to Vail Resorts, company operating in opioid-devastated communities
2019-10-03 - 😈 - Named in California AG amended complaint for contributing to opioid crisis through Purdue Pharma
2020-10-21 - 😈 - Named as one of five Named Sacklers in DOJ civil settlement; family paid USD 225 million to resolve False Claims Act liability
2020-12-17 - 😈 - Testified before Congress and deflected personal blame for opioid crisis despite documented board decisions approving aggressive marketing
2025-01-23 - 😈 - Named in USD 7.4 billion national settlement with all US states, ending Sackler family control of Purdue Pharma
Analysis
Federal prosecutors documented that Sackler was one of five family members who, in 2012, directed management to recapture lost opioid market share and then approved the 2013 "Evolve to Excellence" program, targeting physicians already prescribing OxyContin at 25 times the rate of their peers. The Massachusetts AG's complaint further documented that Sackler directed email initiatives targeting Massachusetts prescribers and oversaw payments to doctors to promote an improper savings card scheme.
What makes the record striking is the gap between those documented actions and his public response. In a June 2019 Vanity Fair interview, he told the magazine "facts will show we didn't cause the crisis." At his December 2020 Congressional testimony, he apologized for the epidemic's toll while insisting that board members had been assured by management that the company was operating lawfully. Both the 2020 DOJ civil agreement and the 2025 national settlement resolved without criminal charges or personal admissions of wrongdoing.
Questions
The central question is how to weigh the responsibility of a third-generation family member who joined the board after the company's founding decisions and initial 1990s marketing push. David Sackler joined in 2012, years after Purdue's 2007 federal guilty plea. Does continuing a harm that was already underway carry the same moral weight as initiating it?
The DOJ's specific naming of him as a "Named Sackler" who approved the 2013 Evolve to Excellence program suggests prosecutors believed his decisions were substantively causal, not merely inherited. But the absence of criminal charges — despite the scale of the harm — raises the question of whether civil settlements, however large, provide adequate accountability for conduct that contributed to hundreds of thousands of deaths.
Redemption Arc
The USD 7.4 billion settlement with all US states resolved the Sackler family's civil legal exposure. In his December 2020 Congressional testimony, Sackler expressed regret for the opioid epidemic's toll while maintaining that his family acted within legal bounds.